A comprehensive view of U.S. Food and Drug Administration (FDA). This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Japan’s Eisai Co. reports its injectable Alzheimer’s drug lecanemab, reduced clinical decline in patients with early-stage Alzheimer’s by 27% in late-stage study; Eisai seeks accelerated approval from FDA, with Eisai and Biogen co-promoting the drug
Published: September 28, 2022 by Associated Press
Lilly’s Retevmo selpercatinib in 40 mg, 80 mg capsules receives accelerated clearance by FDA to treat adult patients with advanced or metastatic solid tumors
Published: September 28, 2022 by PBR, Pharmaceutical Business Review
FDA issues new guidelines for 'healthy' food that vary based on the product type; under the guidelines, something that is 'healthy' needs to have the equivalent of a serving of fruits, vegetables, grains, dairy or protein foods
Published: September 28, 2022 by Food Dive
FDA to research and propose a standardized front-of-package labeling system to help consumers more readily understand nutrition information; the labeling could come in the form of star ratings or traffic light images
Published: September 27, 2022 by USA Today Online
Nanopharm, Fluidda partner to accelerate FDA approval of orally inhaled generic products to treat asthma, COPD; firms to use Nanopharm’s in vitro/in silico platform, Fluidda’s Functional Respiratory Imaging platform
Published: September 27, 2022 by Fitch Solutions Sector Intelligence

Ask us about our Tissue & Hygiene market view

Trending Chart

Interactive chart with headline count